A Dose of Digital: Can Pharma Make DTx a Healthy Business?

Digital therapeutics (DTx) are emerging as a potential game-changer in healthcare, offering evidence-based digital interventions to help prevent, manage, or treat specific conditions.

As pharmaceutical companies recognise the potential of DTx to improve patient outcomes, differentiate products, and generate real-world treatment data, they are increasingly seeking to incorporate these digital solutions into their business strategies. 

At the same time, however, the rapid growth of the DTx sector has outpaced the ability of healthcare systems to adapt, leading to regulatory uncertainty and slow adoption rates. In this article, we explore the complex landscape of digital therapeutics and the challenges faced by DTx companies in gaining widespread adoption; we conclude by presenting Ipsos' 5-stage framework for developing a resilient and scalable DTx business. 

Download ‘A Dose Of Digital’

Download ‘The Strategic Art of Pharma Partnerships’

Access more Ipsos Healthcare thought leadership here.

Download

Related news

  • [WEBINAR] KEYS: The Year in Review
    Consumers Events replay

    [WEBINAR] KEYS: The Year in Review

    Join Ipsos for its complimentary KEYS webinar series dedicated to helping brands and organizations better understand the dynamics of today as they prepare for tomorrow.
  • Automotive Disruption and Trends Webinar
    Consumers Events replay

    Automotive Disruption and Trends Webinar

    Revisit Ipsos and SAA for a discussion on the future of mobility based on insights from the 2025 Ipsos Navigator Study.
  • Obesity Week
    Public Health Event

    Obesity Week

    This is a conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations.